<DOC>
	<DOCNO>NCT02010905</DOCNO>
	<brief_summary>Rationale : The prevalence adult patient congenital heart disease ( CHD ) steadily increase last decade , due advance cardiac surgery . A large number patient cope right ventricular ( RV ) volume pressure overload , largely cause residual lesion cardiac surgery childhood . Previous RV overload due pulmonary regurgitation Tetralogy Fallot ( TOF ) lead RV dysfunction . These finding warrant close surveillance RV function , adequate evidence-based pharmacological therapy reduce morbidity mortality young patient group . The renin-angiotensin-aldosterone system ( RAAS ) activate patient ventricular failure , irrespective effect ( left right ) ventricle . Angiotensin convert enzyme ( ACE ) inhibitor angiotensin II receptor blocker ( ARB 's ) drug act inhibitor RAAS . Previously , large trial demonstrate beneficial effect angiotensin convert enzyme ( ACE ) inhibitor morbidity mortality patient acquire left ventricular ( LV ) dysfunction . ARB 's similar effect ACE inhibitor patient acquire LV dysfunction discontinuation side effect cough less frequent . In TOF patient RV overload due pulmonary regurgitation , pulmonary valve replacement lead decrease RV size pulmonary regurgitation . Current guideline advise empiric use RAAS inhibitor right ventricular dysfunction adult patient congenital heart disease . However , actual effect RAAS inhibition right ventricular dysfunction adult TOF patient without severe valvular lesion sufficiently investigate . Therefore , set-up propose study , hypothesize ARB 's beneficial effect RV ejection fraction adult TOF patient RV dysfunction without severe valvular lesion . Objective : improve RV ejection fraction adult TOF patient RV dysfunction without severe valvular lesion . Study design : prospective , multicenter , double-blind , randomize , placebo-controlled trial . Follow two year Study population : adult patient Tetralogy Fallot right ventricular dysfunction , define right ventricular ejection fraction &lt; 50 % without severe valvular lesion Intervention : patient randomize receive either losartan 150 mg daily , placebo regimen . Main study parameters/endpoints : primary endpoint difference change RV ejection fraction , determine cardiovascular magnetic resonance imaging ( CMR ) , treatment control group two year follow-up . Nature extent burden risk associate participation , benefit group relatedness : All investigation , except blood analysis , non-invasive free risk . The burden patient mainly consist time consume visit clinic . At visit time consume : history take physical investigation ( 15 minute ) ; quality life score ( 15 minute ) ; laboratory test ( 6 time venopuncture , total amount blood withdrawn approximately 90ml ) . Cardiopulmonary exercise testing ( 1hour ) , echocardiography ( 15 minute ) CMR ( 45 minute ) part regular medical care . Adverse effect losartan usually limited consist dizziness due hypotension , renal impairment , hyperkalemia liver impairment . We expect change increase RV function intervention group compare control group two-year follow period , would great benefit young study population .</brief_summary>
	<brief_title>Right Ventricular Dysfunction Tetralogy Fallot : Inhibition Renin-angiotensin-aldosterone System</brief_title>
	<detailed_description />
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<mesh_term>Tetralogy Fallot</mesh_term>
	<mesh_term>Ventricular Dysfunction , Right</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>In order eligible participate study , subject must meet following criterion : adult age mentally competent ; Tetralogy Fallot ; right ventricular dysfunction , define right ventricular ejection fraction 50 % low measure Cardiovascular Magnetic Resonance Imaging ( CMR ) . Not moderate tricuspid pulmonary regurgitation moderate pulmonary stenosis measure CMR echocardiography . Incapable give informed consent Hypersensitivity losartan help substance Contraindications CMR Previous current angioedema whether relation use ACE inhibitor ARB Known bilateral renal artery stenosis Current symptomatic hypotension Estimated glomerular filtration rate 30 ml/min low Plasma potassium level 5,5 mmol/L high Moderate severe liver disease : Child Pugh class B C Raised plasma transaminase level three time upper normal limit Current treatment hypertension ACEinhibitor ARB , discontinue Current treatment potassium chloride , trimethoprim , tacrolimus cyclosporine discontinue Pregnant nursing woman Desire child within study period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Losartan</keyword>
</DOC>